Your browser doesn't support javascript.
loading
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi, Kohei; Ikeda, Masafumi; Konishi, Masaru; Nomura, Shogo; Katayama, Hiroshi; Kataoka, Tomoko; Todaka, Akiko; Yanagimoto, Hiroaki; Morinaga, Soichiro; Kobayashi, Shogo; Shimada, Kazuaki; Takahashi, Yu; Nakagohri, Toshio; Gotoh, Kunihito; Kamata, Ken; Shimizu, Yasuhiro; Ueno, Makoto; Ishii, Hiroshi; Okusaka, Takuji; Furuse, Junji.
Afiliación
  • Nakachi K; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Japan; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: knakachi@tochigi-cc.jp.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Konishi M; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nomura S; Japan Clinical Oncology Group Data Center, National Cancer Center Hospital, Tokyo, Japan.
  • Katayama H; Japan Clinical Oncology Group Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kataoka T; Japan Clinical Oncology Group Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yanagimoto H; Department of Surgery, Kansai Medical University, Hirakata, Japan.
  • Morinaga S; Department of Hepato-Biliary and Pancreatic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Kobayashi S; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Shimada K; Clinical Research Support Office, Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Takahashi Y; Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakagohri T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Gotoh K; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Kamata K; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Shimizu Y; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ishii H; Gastrointestinal Medical Oncology, Chiba Cancer Center, Chiba, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Furuse J; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Lancet ; 401(10372): 195-203, 2023 01 21.
Article en En | MEDLINE | ID: mdl-36681415
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Sistema Biliar / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Año: 2023 Tipo del documento: Article